icone plus
Contact
Abonnez-vous aux actualités
Autorisation d’accès précoce refusée à la spécialité TRUQAP (capivasertib).
Voir aussi
Décision d'accès précoce
10/06/2024
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
BaEGr5tMgqgktAVg